News | February 08, 2025
NURA AI Health Screening Centre Bengaluru celebrates 4th anniversary of transforming lives through early detection
Plans underway to expand screening capacity by 50% for greater accessibility
Plans underway to expand screening capacity by 50% for greater accessibility
Dr. Smith brings 30 years of clinical and translational research experience in obesity, diabetes, and metabolism with over 300 scientific publications
Parents, teachers, and caregivers play a vital role in spotting early signs of schizophrenia
GEMTESA is the first and only beta-3 agonist approved for the treatment of men with OAB symptoms who are receiving pharmacological therapy for BPH
Accelerated approval is based on 61% overall response rate compared to 40% in control arm in the
WINREVAIR met primary endpoint of time to first morbidity or mortality event for the treatment of patients with pulmonary arterial hypertension (PAH) functional class III or IV at high risk of mortality
Emraclidine was well-tolerated with an adverse event profile consistent with Phase 1b trial
He has 35+ years of experience in understanding of business and products, analytical ability, eye for detail and computer literacy and knowledge of recent trends.
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency
The samples of both products mentioned in the CDSCO list are spurious and not manufactured by Alkem
Subscribe To Our Newsletter & Stay Updated
